Cargando…
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection an...
Autores principales: | Shehadeh, Lina A., Yu, Kristine, Wang, Liyong, Guevara, Alexandra, Singer, Carlos, Vance, Jeffery, Papapetropoulos, Spyridon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817002/ https://www.ncbi.nlm.nih.gov/pubmed/20161708 http://dx.doi.org/10.1371/journal.pone.0009104 |
Ejemplares similares
-
SRRM2 organizes splicing condensates to regulate alternative splicing
por: Xu, Shaohai, et al.
Publicado: (2022) -
SRRM4-dependent neuron-specific alternative splicing of protrudin transcripts regulates neurite outgrowth
por: Ohnishi, Takafumi, et al.
Publicado: (2017) -
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
por: Coleman, Daniel J., et al.
Publicado: (2020) -
A Mutation in the Srrm4 Gene Causes Alternative Splicing Defects and Deafness in the Bronx Waltzer Mouse
por: Nakano, Yoko, et al.
Publicado: (2012) -
Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer
por: Gan, Yu, et al.
Publicado: (2018)